Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04491942
Title	Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	National Cancer Institute (NCI)
Indications	lung small cell carcinoma endometrial cancer lung non-small cell carcinoma stomach cancer cervical cancer transitional cell carcinoma esophageal cancer triple-receptor negative breast cancer malignant pleural mesothelioma ovarian cancer Advanced Solid Tumor penile cancer biliary tract cancer head and neck cancer
Therapies	BAY1895344 + Cisplatin BAY1895344 + Cisplatin + Gemcitabine
Age Groups:	adult \| senior
Covered Countries	USA \| CAN